{
  "timestamp": "2025-05-01T01:01:45.878375",
  "questionnaire": "cleaned_questionnaire.txt",
  "conversation": [
    {
      "role": "patient",
      "content": "Maybe \"Not really, I still enjoy hobbies I do alone. It's more the social stuff that's hard...\" \n\n2. Feeling down, depressed, or hopeless?"
    },
    {
      "role": "patient",
      "content": "\"I guess not exactly depressed, but I do feel down when I think about how I can't handle social situations. But I don\u2019t see myself as hopeless, just... anxious.\"\n\n3. Feeling more irritable?"
    },
    {
      "role": "patient",
      "content": "\"I don\u2019t get angry, but maybe a bit more short-tempered if plans involve socializing. Like, I\u2019ll get annoyed if someone invites me somewhere last-minute.\"\n\n4. Sleeping less but with energy? Probably not, so patient says \"No, not at all. When I can't sleep, it's because I'm worrying, but I feel tired the next day.\"\n\n5. Starting many projects or risky behaviors? No: \"No, I don't do that. I\u2019m more like the opposite, maybe avoiding activities because of anxiety.\"\n\n6. Anxiety: \"Yes, a lot. Like, if I have to speak in a meeting, my hands shake and I get really nervous. I\u2019d say that\u2019s pretty frequent.\"\n\n7. Panic attacks? \"Sometimes, but not all the time. Maybe once a month if I'm forced into a big group.\"\n\n8. Avoiding anxious situations: \"I avoid parties and gatherings a lot. Like, I\u2019ve turned down invites even for work events.\"\n\n9. Unexplained aches: \"Not really. But when I'm anxious, my stomach aches. But maybe that's normal stress, I guess.\"\n\n10. Unexplained illnesses not taken seriously? \"No, I don't think that\u2019s an issue. Maybe I just worry too much about health.\"\n\n11. Suicidal thoughts? \"No, I don\u2019t want to hurt myself. It's more like I just want to avoid people.\"\n\n12. Hearing voices? \"No, I don\u2019t hear voices. Sometimes I might overthink what others think of me, but not hallucinations.\"\n\n13. Feeling others can hear my thoughts? \"No, not like that. I just worry people are judging me.\"\n\n14. Sleep problems: \"Yes, sometimes I can\u2019t fall asleep because I\u2019m worried about tomorrow's meeting or event.\"\n\n15. Memory issues: \"Hmm, not really. But when I'm anxious, I"
    },
    {
      "role": "assistant",
      "content": "\n<think>\nOkay, I need to create a professional yet compassionate assessment based on the user's query. The user provided a questionnaire with all \"No response\" answers. My task is to follow the exact structure specified. Let me break down each section step by step.\n\nFirst, the compassionate summary paragraph. I have to acknowledge the lack of responses without judgment, express concern, and emphasize the need for further evaluation. Make sure to use empathetic language here.\n\nNext, the Diagnosis section. Since there's no data, I can't assign a definitive diagnosis. The DSM-5 mentions SSD, but since there's no information, maybe the diagnosis is \"Insufficient information for diagnosis\". But the user mentioned not to default to SSD unless warranted. The answer should reflect that. Maybe use \"Provisional clinical concern\" instead of a formal diagnosis.\n\nIn the Reasoning section, I need to explain why no diagnosis can be made. Mention that all responses are missing, so no symptoms can be assessed. Highlight the inability to rule out risks like psychosis, depression, etc., and the need for a clinical interview.\n\nFor Next Steps, list actionable items like in-person evaluation, collateral info, cognitive assessment, and motivational engagement strategies. Make sure each step is clear and numbered.\n\nNow, check formatting: use the specified tags. Medical terms like \"SSD\" need to be in <med> tags, symptoms (though none are given), so maybe not needed here. Quotes are not present, so just leave those out.\n\nWait, the user's example didn't use quotes, so I can skip that. Ensure all four sections are present in order. Section headings must have double asterisks. Keep paragraphs concise and professional.\n\nAvoid mentioning Somatic Symptom Disorder unless it's applicable. Since there's no data, can't assume that. Focus on the lack of info being the main issue.\n\nDouble-check the structure: summary, diagnosis heading, reasoning, next steps. Make sure each section is separated by a single line.\n\nAlright, let's draft each part step by step, ensuring all instructions are followed precisely.\n</think>\n\nThe patient\u2019s lack of response to all screening questions highlights a significant barrier to clinical assessment. While this may reflect challenges with self-reporting due to distress, confusion, or disengagement, it underscores the urgency of further evaluation to understand their emotional, cognitive, or interpersonal experiences that may be impacting their ability to engage in the process. It is critical to approach this with empathy, as unreported symptoms could include severe distress, trauma, or neurocognitive factors requiring immediate attention.  \n\n**Diagnosis:**  \nProvisional clinical concern: Incomplete assessment precluding definitive diagnosis  \n\n**Reasoning:**  \nA definitive <med>diagnosis</med> cannot be established due to <sym>complete non-response</sym> to all screening items. Key factors include:  \n1. Absence of self-reported symptoms to assess for mood disorders (e.g., depression, mania), anxiety disorders, psychotic symptoms, or trauma-related distress.  \n2. Unassessed risk for <med>suicidality</med> (<sym>Q10</sym> unanswered) or <med>psychosis</med> (<sym>Q11\u2013Q12</sym> unanswered).  \n3. Potential barriers to evaluation: alexithymia, cognitive impairment, or motivational/relational challenges impacting their ability to complete the questionnaire.  \n\n**Recommended Next Steps/Treatment Options:**  \n1. Conduct an in-person clinical interview to explore barriers to self-reporting, assess for cognitive/psychiatric symptoms, and address engagement.  \n2. Perform collateral assessments (e.g., family reports, medical records) to gather objective data.  \n3. Evaluate for neurocognitive/communication impairments (e.g., <med>alexithymia</med>, substance intoxication, or <med>mild neurocognitive disorder</med>) that may explain the lack of response.  \n4. Use clinician-rated assessments (e.g., PHQ-9, GAF, or functional evaluations) to quantify symptom severity.  \n5. Prioritize <sym>suicide risk</sym> and medical stability during initial evaluation.",
      "rag_usage": {
        "documents": [
          {
            "title": "APA_DSM-5-Somatic-Symptom-Disorder.pdf",
            "score": 0.7146,
            "highlight": "While DSM-IV was organized centrally around the concept of  medically unexplained symptoms, DSM-5 criteria instead emphasize the degree to which a patient \u2019s  thoughts, feelings and behaviors about their somatic symptoms are disproportionate or excessive.",
            "excerpt": "to make the criteria more useful to non-psychiatric care providers. \nTo ensure that the new criteria...",
            "relevance_explanation": "Moderate relevance: Contains related terms \"which\", \"emphasize\", \"patient\", and 3 more matching aspects of your query."
          },
          {
            "title": "APA_DSM-5-Schizophrenia.pdf",
            "score": 0.7067,
            "highlight": "Identifying individuals with an increased risk for developing a psychotic disorder is  significant for effective early intervention, but more study is needed to ensure that attenuated psycho - sis syndrome can be reliably diagnosed.",
            "excerpt": "h before their consideration as formal disorders. This potential category would \nidentify a person w...",
            "relevance_explanation": "Moderate relevance: Contains related terms \"psychotic\", \"significant\", \"identifying\", and 4 more matching aspects of your query."
          },
          {
            "title": "APA_DSM-5-Conduct-Disorder.pdf",
            "score": 0.6814,
            "highlight": "In addition to treatment, the specifier will impact the research on persons with  conduct disorder by designating groups of patients with more similar causal factors.",
            "excerpt": "he disorder and a different treatment response. Thus the specifier will allow clinicians to more ac ...",
            "relevance_explanation": "Moderate relevance: Contains related terms \"treatment\", \"conduct\", \"factors\" matching aspects of your query."
          },
          {
            "title": "APA_DSM-5-Personality-Disorder.pdf",
            "score": 0.6747,
            "highlight": "This approach also includes a diag - nosis of Personality Disorder\u2014 Trait Specified (PD-TS) that could be made when a Personality Disorder is  considered present, but the criteria for a specific personality disorder are not fully met.",
            "excerpt": "ncluded evaluation of impairments \nin personality functioning (how an individual typically experienc...",
            "relevance_explanation": "Moderate relevance: Contains related terms \"not\", \"could\", \"this\", and 3 more matching aspects of your query."
          },
          {
            "title": "APA_DSM-5-Mild-Neurocognitive-Disorder.pdf",
            "score": 0.6725,
            "highlight": "Process for a New Diagnosis New diagnoses were included in DSM-5 only after a comprehensive review of the scientific literature;  full discussion by Work Group members; review by the DSM-5 Task Force, Scientific Review Committee,  and Clinical and Public Health Committee; and, finally, evaluation by the American Psychiatric Associa - tion\u2019s Board of Trust ees.",
            "excerpt": "ment and may prevent or slow progression. Researchers \nwill evaluate how well the new diagnostic cri...",
            "relevance_explanation": "Moderate relevance: Contains related terms \"clinical\", \"health\", \"task\", and 3 more matching aspects of your query."
          }
        ],
        "stats": {
          "query": "mental health diagnosis for patient with symptoms: \n<think>\nOkay, let's tackle this. The user provided a list of questions from a patient questionnaire where all answers are \"No response provided\". I need to act as a mental health professional and analyze this.\n\nFirst, the main task is to identify main symptoms, patterns, potential clinical areas, risk factors, and summarize in clinical terms. Since all answers are missing, I need to focus on the absence of responses rather than the content.\n\n1. Main Symptoms and Concerns: Since there are no answers, I can't determine symptoms, but the non-response itself might be significant. Maybe the patient didn't understand the questions, refused to answer, or had limited engagement. It could indicate reluctance to engage in assessment, which is a concern.\n\n2. Patterns: All questions unanswered. The pattern is complete lack of engagement with the questionnaire. Maybe the patient didn't complete it, or there was an oversight. Could be intentional refusal, or technical issue. But clinically, I should consider the patient's willingness to participate.\n\n3. Potential Clinical Areas: The lack of response might relate to alexithymia (difficulty identifying emotions), poor insight, or resistance to treatment. It could also point to issues like depression or anxiety where the patient feels overwhelmed to respond. Alternatively, cognitive impairments affecting comprehension or memory? Maybe substance use if they were under the influence, but there's no data here.\n\n4. Risk Factors: Inability to engage in assessment is a risk because it hinders proper diagnosis and treatment. Without data, it's hard to assess actual symptoms. Also, if they're avoiding the questions, could there be suicidal ideation they're not reporting? But since Q10 (hurting yourself) is also unanswered, that's a concern. But can't confirm without info. Maybe risk of non-compliance with treatment.\n\n5. Summary: Need to note the absence of responses as a clinical issue itself. Highlight that the lack of data prevents accurate assessment, suggesting the need for a clinical interview to explore engagement, cognitive state, and possible barriers to assessment. Mention the inability to assess common mental health concerns, including mood, anxiety, psychotic symptoms, etc., due to no responses.\n\nWait, but the user wants me to list all these points in a structured way. Also, must avoid speculation. So I can't assume why they didn't answer. Just state the facts that all questions were unanswered, which hinders assessment, and note possible areas that could be problematic but are not evaluated here. Also, mention that without responses, risk factors like self-harm (Q10, Q11 for psychosis, etc.) can't be assessed, which is a critical concern. Maybe note that the lack of responses is a clinical concern in itself, pointing to possible issues like resistance, lack of insight, or other factors affecting their ability to engage.\n\nNeed to structure the answer as per the user's instructions. Also, use professional terms like \"non-response to all items\", \"absence of clinical data\", \"impairment in assessment process\", \"risk of undetected symptoms\", etc.\n\nI should make sure not to make assumptions beyond what's given. Just state the observed pattern (all no responses) and what that implies for clinical next steps. Also, emphasize the need for further evaluation through clinical interview or other assessments since the questionnaire is unhelpful here.\n</think>\n\n**Clinical Observation Summary**  \n\n### 1. **Main Symptoms and Concerns**  \n- **No self-reported symptoms**: Patient provided no responses to all 23 items, precluding assessment of mood, anxiety, psychotic symptoms, trauma-related concerns, cognitive/functional impairment, or substance use.  \n- **Non-engagement with assessment tools**: Failure to complete questionnaire raises concerns about impaired insight, motivation, or ability to self-report.  \n\n### 2. **Patterns in Responses**  \n- **Complete absence of data**: All items (Q1\u2013Q23) were unresponsive, suggesting systematic non-engagement rather than selective omission.  \n- **No observable response patterns** (e.g., symptom clusters, under/overreporting) due to lack of input.  \n\n### 3. **Potential Areas of Clinical Significance**  \n- **Impaired insight or self-awareness**: Inability or unwillingness to report symptoms may indicate alexithymia, cognitive impairment, or denial of distress.  \n- **Barriers to treatment engagement**: Non-response could reflect distrust, ambivalence, or motivational challenges requiring intervention.  \n- **Unmeasured risks**: Key concerns (e.g., suicidal ideation, psychosis, substance use, dissociation, somatic symptoms) remain unassessed and could be present but undetectable via this tool.  \n\n### 4. **Risk Factors/Warning Signs**  \n- **Undetected self-harm risk**: Failure to answer Q10 (suicidal ideation) necessitates direct clinical inquiry.  \n- **Untreated psychotic symptoms**: Unanswered Q11/Q12 (auditory hallucinations, thought interference) precludes ruling out psychotic disorders.  \n- **Substance use**: No data on Q19/Q20/Q23 (alcohol, tobacco, non-prescription drug use) limits assessment of potential comorbidities.  \n\n### 5. **Summary (Clinical Language)**  \nThe patient\u2019s **complete non-response** to the structured questionnaire precludes meaningful symptom evaluation and limits identification of diagnostic or risk factors. Key concerns include:  \n- Impaired ability or willingness to engage in self-report assessment.  \n- Unmeasured risk for mood disorders, anxiety, psychosis, and substance use.  \n- Potential barriers to treatment, including motivational or cognitive factors.  \n\n**Immediate clinical priorities**:  \n- Conduct a **face-to-face clinical interview** to explore engagement barriers, assess cognitive/emotional state, and address risks (e.g., suicidal/harm potential, psychosis).  \n- Rule out alexithymia, neurocognitive impairment, or externalizing factors (e.g., substance intoxication) impacting self-report.  \n- Re-administer assessments using alternative methods (e.g., clinician-rated scales, collateral information) if engagement improves.  \n\n**Critical Note**: Further evaluation is urgently required to assess unmeasured risks and establish a therapeutic alliance to facilitate meaningful assessment.",
          "results_count": 5,
          "requested_count": 5,
          "avg_score": 0.69
        },
        "count": 5
      }
    }
  ],
  "diagnosis": "The patient\u2019s lack of response to all screening questions highlights a significant barrier to clinical assessment. While this may reflect challenges with self-reporting due to distress, confusion, or disengagement, it underscores the urgency of further evaluation to understand their emotional, cognitive, or interpersonal experiences that may be impacting their ability to engage in the process. It is critical to approach this with empathy, as unreported symptoms could include severe distress, trauma, or neurocognitive factors requiring immediate attention.  \n\n**Diagnosis:**  \nProvisional clinical concern: Incomplete assessment precluding definitive diagnosis  \n\n**Reasoning:**  \nA definitive <med>diagnosis</med> cannot be established due to <sym>complete non-response</sym> to all screening items. Key factors include:  \n1. Absence of self-reported symptoms to assess for mood disorders (e.g., depression, mania), anxiety disorders, psychotic symptoms, or trauma-related distress.  \n2. Unassessed risk for <med>suicidality</med> (<sym>Q10</sym> unanswered) or <med>psychosis</med> (<sym>Q11\u2013Q12</sym> unanswered).  \n3. Potential barriers to evaluation: alexithymia, cognitive impairment, or motivational/relational challenges impacting their ability to complete the questionnaire.  \n\n**Recommended Next Steps/Treatment Options:**  \n1. Conduct an in-person clinical interview to explore barriers to self-reporting, assess for cognitive/psychiatric symptoms, and address engagement.  \n2. Perform collateral assessments (e.g., family reports, medical records) to gather objective data.  \n3. Evaluate for neurocognitive/communication impairments (e.g., <med>alexithymia</med>, substance intoxication, or <med>mild neurocognitive disorder</med>) that may explain the lack of response.  \n4. Use clinician-rated assessments (e.g., PHQ-9, GAF, or functional evaluations) to quantify symptom severity.  \n5. Prioritize <sym>suicide risk</sym> and medical stability during initial evaluation.",
  "metadata": {
    "assistant_model": "qwen-qwq-32b",
    "patient_model": "qwen-qwq-32b",
    "patient_profile": "social_anxiety",
    "question_count": 23,
    "duration": 22922.331352233887,
    "full_conversation": true
  },
  "timing_metrics": {
    "conversation_generation_time": 10.51469898223877,
    "diagnosis_generation_time": 6.444999933242798,
    "rag_evaluation_time": 5.0067901611328125e-06,
    "total_time": 16.959710359573364
  },
  "rag_summary": {
    "total_rag_queries": 1,
    "total_documents_accessed": 5,
    "documents_accessed": {
      "APA_DSM-5-Somatic-Symptom-Disorder.pdf": {
        "access_count": 1,
        "highest_score": 0.7146,
        "average_score": 0.7146,
        "example_excerpt": "to make the criteria more useful to non-psychiatric care providers. \nTo ensure that the new criteria...",
        "relevance_explanation": "Moderate relevance: Contains related terms \"which\", \"emphasize\", \"patient\", and 3 more matching aspects of your query."
      },
      "APA_DSM-5-Schizophrenia.pdf": {
        "access_count": 1,
        "highest_score": 0.7067,
        "average_score": 0.7067,
        "example_excerpt": "h before their consideration as formal disorders. This potential category would \nidentify a person w...",
        "relevance_explanation": "Moderate relevance: Contains related terms \"psychotic\", \"significant\", \"identifying\", and 4 more matching aspects of your query."
      },
      "APA_DSM-5-Conduct-Disorder.pdf": {
        "access_count": 1,
        "highest_score": 0.6814,
        "average_score": 0.6814,
        "example_excerpt": "he disorder and a different treatment response. Thus the specifier will allow clinicians to more ac ...",
        "relevance_explanation": "Moderate relevance: Contains related terms \"treatment\", \"conduct\", \"factors\" matching aspects of your query."
      },
      "APA_DSM-5-Personality-Disorder.pdf": {
        "access_count": 1,
        "highest_score": 0.6747,
        "average_score": 0.6747,
        "example_excerpt": "ncluded evaluation of impairments \nin personality functioning (how an individual typically experienc...",
        "relevance_explanation": "Moderate relevance: Contains related terms \"not\", \"could\", \"this\", and 3 more matching aspects of your query."
      },
      "APA_DSM-5-Mild-Neurocognitive-Disorder.pdf": {
        "access_count": 1,
        "highest_score": 0.6725,
        "average_score": 0.6725,
        "example_excerpt": "ment and may prevent or slow progression. Researchers \nwill evaluate how well the new diagnostic cri...",
        "relevance_explanation": "Moderate relevance: Contains related terms \"clinical\", \"health\", \"task\", and 3 more matching aspects of your query."
      }
    },
    "rag_disabled": false,
    "evaluation_metrics": {
      "contextual_relevancy": {
        "average_score": null
      },
      "faithfulness": {
        "average_score": null
      },
      "answer_relevancy": {
        "average_score": null
      },
      "overall": {
        "average_score": null
      }
    }
  },
  "evaluation": {
    "timestamp": "2025-05-01 07:59:34",
    "provider": "groq",
    "model": "meta-llama/llama-4-scout-17b-16e-instruct",
    "llm_evaluation": {
      "timestamp": "2025-05-01 07:59:34",
      "model": "meta-llama/llama-4-scout-17b-16e-instruct",
      "rubric_scores": {
        "dsm_coverage": 2,
        "clinical_relevance": 3,
        "consistency": 3,
        "diagnostic_justification": 2,
        "empathy": 2
      },
      "explanations": {
        "dsm_coverage": "The conversation only superficially addressed a few DSM-5 dimensions, primarily focusing on anxiety and depression. Many critical areas, such as mania, psychosis, repetitive thoughts/behaviors, dissociation, personality functioning, and substance use, were either omitted or minimally explored. The therapist failed to systematically assess most DSM-5 dimensions, leading to significant gaps in understanding the patient's symptoms.",
        "clinical_relevance": "The questions asked generally align with DSM-5 criteria but contain some inaccuracies and vague phrasing. The therapist did not precisely reflect DSM-5 criteria in their questions, and some queries seemed to conflate or confuse different constructs. For example, the therapist did not adequately distinguish between depression and anxiety or assess for suicidal ideation with sufficient depth.",
        "consistency": "The dialogue has noticeable logical inconsistencies and occasionally disrupts coherence and understanding. The therapist did not follow up on concerning disclosures, such as the patient's suicidal ideation or psychosis, and abruptly changed topics without exploring the patient's responses in depth. The conversation lacked a smooth flow and coherent arc.",
        "diagnostic_justification": "The diagnosis rarely aligns with the patient's responses, and the justification is superficial or unclear. The therapist did not explicitly link the patient's symptoms to DSM-5 criteria or consider alternative diagnoses. The diagnostic conclusion seems to focus on the patient's inability to complete the assessment rather than their actual symptoms and experiences.",
        "empathy": "The therapist's responses occasionally show empathy, but interactions sometimes seem robotic, impersonal, or inappropriate. The therapist did not consistently acknowledge the patient's distress or tailor responses to their emotional state. The conversation could benefit from a warmer, more personalized approach to engage the patient and address their emotional needs."
      },
      "overall_comments": "The conversation demonstrates a need for significant improvement across all criteria. The therapist failed to systematically assess the patient's symptoms, leading to a provisional diagnosis of 'incomplete assessment precluding definitive diagnosis.' While the therapist showed some awareness of critical domains, their approach was inconsistent, and their questions often lacked clinical precision. The conversation would benefit from a more structured and empathetic approach to better understand the patient's experiences and symptoms.",
      "average_score": 2.4,
      "diagnosis_accuracy": {
        "matches_profile": false,
        "confidence": 4,
        "explanation": "The diagnosis does not explicitly mention social anxiety or related terms. Instead, it highlights the challenges with self-reporting and the inability to establish a definitive diagnosis due to complete non-response to all screening items. The focus is on the assessment process and potential barriers to evaluation rather than identifying a specific condition like social anxiety.",
        "classification": "other"
      },
      "diagnosis_classification": {
        "expected_profile": "social_anxiety",
        "classified_as": "other",
        "match": false,
        "confidence": 4
      },
      "question_evaluation": {
        "total_questions": 0,
        "questions_asked": 0,
        "percentage_asked": 0,
        "quality_score": 0,
        "explanation": "Could not evaluate question coverage due to technical issues.",
        "question_analysis": []
      },
      "evaluation_time": 3.234194755554199
    },
    "extended_metrics": {
      "coherence": {
        "global_coherence": 0.6210590623408415,
        "local_coherence": 0.6885457878501321,
        "window_coherence": 0.6523053606052045
      },
      "readability": {
        "flesch_kincaid_grade": 9.93,
        "gunning_fog_index": 4.03,
        "flesch_reading_ease": 41.36
      },
      "diversity": {
        "distinct_1": 0.6037414965986394,
        "distinct_2": 0.938671209540034,
        "distinct_3": 0.9829351535836177
      }
    },
    "diagnosis_evaluation": {
      "expected": "social_anxiety",
      "predicted": "The patient\u2019s lack of response to all screening questions highlights a significant barrier to clinical assessment. While this may reflect challenges with self-reporting due to distress, confusion, or disengagement, it underscores the urgency of further evaluation to understand their emotional, cognitive, or interpersonal experiences that may be impacting their ability to engage in the process. It is critical to approach this with empathy, as unreported symptoms could include severe distress, trauma, or neurocognitive factors requiring immediate attention.  \n\n**Diagnosis:**  \nProvisional clinical concern: Incomplete assessment precluding definitive diagnosis  \n\n**Reasoning:**  \nA definitive <med>diagnosis</med> cannot be established due to <sym>complete non-response</sym> to all screening items. Key factors include:  \n1. Absence of self-reported symptoms to assess for mood disorders (e.g., depression, mania), anxiety disorders, psychotic symptoms, or trauma-related distress.  \n2. Unassessed risk for <med>suicidality</med> (<sym>Q10</sym> unanswered) or <med>psychosis</med> (<sym>Q11\u2013Q12</sym> unanswered).  \n3. Potential barriers to evaluation: alexithymia, cognitive impairment, or motivational/relational challenges impacting their ability to complete the questionnaire.  \n\n**Recommended Next Steps/Treatment Options:**  \n1. Conduct an in-person clinical interview to explore barriers to self-reporting, assess for cognitive/psychiatric symptoms, and address engagement.  \n2. Perform collateral assessments (e.g., family reports, medical records) to gather objective data.  \n3. Evaluate for neurocognitive/communication impairments (e.g., <med>alexithymia</med>, substance intoxication, or <med>mild neurocognitive disorder</med>) that may explain the lack of response.  \n4. Use clinician-rated assessments (e.g., PHQ-9, GAF, or functional evaluations) to quantify symptom severity.  \n5. Prioritize <sym>suicide risk</sym> and medical stability during initial evaluation.",
      "matches": false,
      "classification": "other",
      "classification_confidence": 4
    }
  }
}